Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

Leeds webinar index image 3x2

Managing patients with type 2 diabetes—a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This webinar has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice. Products are discussed.
View Jardiance®(empagliflozin) prescribing and adverse event reporting information
PC-GB-103199 March 2021

20210315 Carl Deaney

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This promotional educational webinar has been organised and funded by Takeda UK Ltd.
View prescribing information and adverse event reporting information.
C-APROM/UK/VIP/0301
Date of preparation: March 2021

James Calvert webinar banner 3x2

Chronic obstructive pulmonary disease: managing breathlessness

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103138  Date of preparation: November 2020

Asthma webinar image

What are our options for children with severe asthma?

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103140  Date of preparation: November 2020

COPD webinar image

The appropriate use of inhaled corticosteroids (ICS) in COPD

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103139  Date of preparation: November 2020

Animation index image

Respimat® Soft Mist reusable inhaler: patient benefits and environmental impact

Commissioned by Boehringer Ingelheim Limited

This promotional animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice
View prescribing information
PC-GB-103871 February 2021

Trajenta animation updated index image

Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

Bronchiectasis video index image

Five things you need to know about… bronchiectasis

By Dr Kevin Gruffydd-Jones

In the first of a new series of videos, Dr Kevin Gruffydd-Jones highlights five things you need to know about bronchiectasis

5-minute video_Chronic respiratory conditions and COVID-19-v2

NICE guidance on respiratory conditions and COVID-19: 5-minute video

By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context

Coronavirus visualisation dark

Death certification in COVID-19: 5-minute video

By

Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak

Soprobec FDG image update_index image

Soprobec (beclometasone dipropionate) pMDI

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 V2 March 2021

Prostap FDG

PROSTAP® DCS (leuprorelin acetate)

Commissioned by Takeda UK Ltd

This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd. Information intended for healthcare professionals only.
View prescribing information here

C-APROM/UK/LEU/0075 February 2021

Nutramigen Puramino Index Image

Nutramigen* PURAMINO*

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020

Nutramigen LGG Index Image

Nutramigen* 1, 2 & 3 LGG®

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020

20201016 Saxenda FDG digital V2 image

Formulary decision guide: Saxenda® (liraglutide injection 3 mg)

Commissioned by Novo Nordisk

This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only. 
Click here for the Prescribing Information and Adverse Events Reporting.

UK20SX00110
Date of preparation: October 2020

Final version - GiP supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103451 Date of preparation: January 2021

GiP Index Image

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice
View prescribing information
PC-GB-103142 November 2020

Front cover 20201202 Plenvu supplement December 2020 PI

Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK

Commissioned by Norgine Pharmaceuticals Limited

This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021

20210209 Takeda supplement V1 front cover image

Switching appropriate patients with type 2 diabetes to alogliptin from existing DPP-4 inhibitors: experience and outcomes from three Clinical Commissioning Groups and Local Health Boards

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by Takeda UK Ltd. It has been developed in partnership with Grey Bear Consultancy and published by Guidelines in Practice.
View prescribing information
C-APROM/UK/VIP/0326
Date of preparation: February 2021

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Index image_Soprobec supplement_PI update

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement that aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Leeds supplement_digital_index image

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Celltrion supplement cover

Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust

Commissioned by Celltrion Healthcare UK Ltd

This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D (1) October 2020

FINAL Psoriasis supplement index image

High cost drugs in psoriasis: how to optimise patient care and budgets

Commissioned by Almirall Ltd

This supplement has been commissioned and funded by Almirall Ltd and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals only.
UK-NOP-2000055

Optimised patient pathway for infertility

An optimised patient pathway for the treatment of heterosexual patients with infertility

Commissioned by Merck Serono Ltd

This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

20200311 DPP-4 inhibitor GinP supplement v10 digital version draft

Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities

Commissioned by Boehringer Ingelheim Limited

This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

FINAL Obesity algorithm checklist image

Implementing the Guidelines algorithm on managing obesity in primary care

Supported by an educational grant from Novo Nordisk Limited

Guidelines in Practice approached Novo Nordisk Ltd for an educational grant to support the production of an implementation checklist. Information intended for UK healthcare professionals only.
Date of preparation: January 2021

FINAL Allergic rhinitis checklist image

Implementing the Guidelines algorithm on identifying and managing allergic rhinitis in the asthma population

Supported by an educational grant from Mylan

Information intended for healthcare professionals only.

PCDS acne checklist

Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for acne vulgaris

Supported by an educational grant from Galderma UK Ltd

Information intended for healthcare professionals only.

Evenity index image

Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280

Commissioned by UCB Pharma Ltd

The production of this Guidelines card has been commissioned by UCB Pharma Ltd. 
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020

20210203 Beovu TA card front cover image

NICE Technology Appraisal 672: ▼Brolucizumab for treating wet age-related macular degeneration

Commissioned by Novartis Pharmaceuticals UK Ltd

The printing of this Guidelines summary card has been commissioned by Novartis Pharmaceuticals UK Ltd. Information intended for UK healthcare professionals only.
Click here for Prescribing information and Adverse Event Reporting.

MLR ID 103903
Date of preparation: February 2021

20201022 SMC card hosting page image new PI V1

▼Brolucizumab (Beovu®) 120mg/mL solution for injection in pre-filled syringe SMC2272

Commissioned by Novartis Pharmaceuticals UK Ltd

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. Information intended for healthcare professionals only.
Click here for Prescribing information and Adverse Event Reporting.

BEO20-C089b (1)
Date of preparation: October 2020

Trajenta diabetes flyer v18 cover

Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.

PCDS AK guideline reprint - digital

Actinic keratosis (syn. solar keratosis)—Primary Care Dermatology Society

Commissioned by Almirall Ltd

The production, printing, and distribution of this Guidelines reprint has been commissioned and funded by Almirall Ltd. Information intended for UK healthcare professionals only.

UK-ATK-2100001 March 2021

Screenshot 2021-02-17 at 15.40.45

Dr Girish Gupta–Lunchtime sponsored symposium: Managing acne with topical therapies

Commissioned by Galderma UK Ltd

This video has been commissioned and funded by Galderma and was recorded for Guidelines Live 2020. Please see the bottom of the page for the full disclaimer.
UKI-EDG-2100012   Date of preparation: March 2021

Takeda logo

Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network

This advertorial has been commissioned and developed by Takeda UK Ltd. Information intended for UK healthcare professionals only.
View prescribing information.
C-APROM/UK/VIP/0298
Date of preparation: February 2021

Resources (which contain promotional information) provided by Norgine.
UKE-HEP-XIF-2000005 Date of preparation: January 2021
  • Best practice in hepatic encephalopathy

  • Consensus statement: identification and management of hepatic encephalopathy